Cittadine Andrew bought MNPR
December 2, 2025 · Form 4 insider transaction
Cittadine Andrew bought 8,969 shares of Monopar Therapeutics Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 6 days after the transaction.
Direction
Acquired (buy-side)
Shares
8,969
Price
$0.00
Total value
N/A
InsiderCittadine Andrew
Role—
SecurityStock Options
Transaction codeA: Grant or award
Transaction dateDecember 2, 2025
Filing dateDecember 8, 2025
Shares owned after8,969
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Options vest 6/48ths on June 30, 2026, and 1/48th per month thereafter.